Psoriasis

CLINICAL_TRIALS trial_result · 2025-04-30

Clinical Trial Update: An Exploratory Study to Evaluate a Digital Intervention to Disrupt Scratching in Atopic Dermatitis and Psoriasis [NA]

This clinical trial update reports the completion of a study evaluating a digital intervention designed to disrupt scratching in adults with…

CLINICAL_TRIALS trial_result · 2025-04-27

Clinical Trial Update: A Study of IBI112 in Chinese Patients With Psoriasis Who Were Previously Treated With Biologics [Phase 2]

Phase 2 trial update of IBI112 in Chinese patients with psoriasis who were previously treated with biologics has completed.

CLINICAL_TRIALS trial_result · 2025-04-27

Clinical Trial Update: A Study of Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or Psoriasis [Phase 1]

Phase 1 study of ustekinumab in pediatric participants with Juvenile Psoriatic Arthritis or psoriasis has completed.

CLINICAL_TRIALS trial_result · 2025-04-02

Clinical Trial Update: TYK2 Inhibition in Paradoxical Psoriasis [Phase 2, Phase 3]

Terminated Phase 2/Phase 3 trial evaluating a TYK2 inhibitor for psoriasis.

CLINICAL_TRIALS trial_result · 2025-03-30

Clinical Trial Update: Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis [Phase 2]

This Phase 2 trial evaluated the safety, pharmacokinetics, and efficacy of RA-18C3 in adults with moderate-to-severe psoriasis. The study ha…

CLINICAL_TRIALS trial_result · 2025-03-30

Clinical Trial Update: ACT-128800 in Patients With Moderate to Severe Chronic Plaque Psoriasis [Phase 2]

A Phase 2 trial of ACT-128800 in patients with moderate to severe chronic plaque psoriasis has completed. The document notes the study statu…

CLINICAL_TRIALS trial_result · 2025-03-28

Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants [Phase 3]

Phase 3 pediatric trial evaluating subcutaneously administered guselkumab for chronic plaque psoriasis shows active/not recruiting with resu…

CLINICAL_TRIALS trial_result · 2025-03-28

Clinical Trial Update: Pleiotropic Role of TRPV1 in Psoriasis Inflammation [NA]

This completed clinical trial investigates the role of TRPV1 signaling in psoriasis-related inflammation. The study, conducted by University…

CLINICAL_TRIALS trial_result · 2025-03-25

Clinical Trial Update: Efficacy and Safety Study of HRO350 in Patients with Mild-to-moderate Psoriasis (the 'HeROPA' Study). [Phase 2]

Phase 2 study evaluating the efficacy and safety of HRO350 in mild-to-moderate psoriasis has completed.

CLINICAL_TRIALS trial_result · 2025-03-25

Clinical Trial Update: A Clinical Study of TQH2929 in Healthy Adult Subjects [Phase 1]

A Phase 1 study of TQH2929 in healthy adult subjects has completed, with psoriasis listed as the condition studied.

CLINICAL_TRIALS trial_result · 2025-03-21

Clinical Trial Update: Impact of the Mediterranean Diet on Patients with Psoriasis [NA]

This completed clinical trial investigated the effects of the Mediterranean diet on patients with psoriasis, including assessment of associa…

CLINICAL_TRIALS trial_result · 2025-03-18

Clinical Trial Update: Bioequivalence Test of Hemay005 Tablets [Phase 1]

Completed Phase 1 bioequivalence study of Hemay005 tablets for psoriasis.

CLINICAL_TRIALS trial_result · 2025-03-17

Clinical Trial Update: Real World Study on the Efficacy and Safety of Apremilast in Chinese Patients With Moderate to Severe Plaque Psoriasis, a Multi Center, Prospective, Observational Trial（REACT）

A completed real-world, prospective observational study assessing the effectiveness and safety of apremilast in Chinese adults with moderate…

CLINICAL_TRIALS trial_result · 2025-03-13

Clinical Trial Update: Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis [Phase 4]

Phase 4 trial update showing efficacy and safety of deucravacitinib versus placebo in adults with moderate-to-severe scalp psoriasis, with r…

CLINICAL_TRIALS trial_result · 2025-03-13

Clinical Trial Update: Interest of LC-OCT for Diagnosing Inflammatory Dermatoses: ODIN (OCT Dermotoses INflammatoires)

ODIN is a completed clinical trial evaluating the use of LC-OCT to diagnose inflammatory dermatoses, assessing its potential diagnostic valu…

CLINICAL_TRIALS trial_result · 2025-03-12

Clinical Trial Update: A Herbal Compound for Psoriasis [Phase 2]

A Phase 2 clinical trial evaluating a herbal compound for psoriasis is currently active but not recruiting.

CLINICAL_TRIALS trial_result · 2025-03-07

Clinical Trial Update: A Study to Test How Well Different Doses of BI 765250 Are Tolerated by People With a Skin Disease Called Plaque Psoriasis [Phase 1]

A Phase 1 trial assessing tolerability of multiple doses of BI 765250 in people with plaque psoriasis; the study has completed.

CLINICAL_TRIALS trial_result · 2025-03-06

Clinical Trial Update: Serum, Cellular and Imaging Markers of Arthritis in Psoriasis Patients

A completed clinical trial investigating serum, cellular, and imaging biomarkers of arthritis in psoriasis patients.

CLINICAL_TRIALS trial_result · 2025-02-28

Clinical Trial Update: A Phase 2 Study of Efficacy and Safety of AK111 in Subjects With Moderate-to-Severe Psoriasis [Phase 2]

An update on a Phase 2 trial evaluating AK111 for moderate-to-severe psoriasis; the study has completed.

CLINICAL_TRIALS trial_result · 2025-02-28

Clinical Trial Update: A Study of AK111 in Healthy Subjects [Phase 1]

Phase 1 trial evaluating AK111 in healthy subjects has completed. Psoriasis is listed as the condition in the study details.